CEO SERVERANCE AGREEMENTCeo Serverance Agreement • September 14th, 2015 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledSeptember 14th, 2015 Company Industry JurisdictionThis CEO Severance Agreement (the “Agreement”) is entered into as of July 7, 2015 (the “Effective Date”) by and between David G. Lowe, Ph.D. (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).